{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T19:09:26Z","timestamp":1774292966442,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"44","license":[{"start":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2024,10,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Embryogenesis is a vulnerable time. Mutations in developmental cells can result in the wide dissemination of cells predisposed to disease within mature organs. We characterised the evolutionary history of four synchronous renal tumours from a 14-year-old girl using whole genome sequencing alongside single cell and bulk transcriptomic sequencing. Phylogenetic reconstruction timed the origin of all tumours to a multipotent embryonic cell committed to the right kidney, around 4 weeks post-conception. Biochemical and structural analysis of their shared\n                    <jats:italic>MTOR<\/jats:italic>\n                    mutation, absent from normal tissues, demonstrates enhanced protein flexibility, enabling a FAT domain hinge to dramatically increase activity of mTORC1 and mTORC2. Developmental mutations, not usually detected in traditional genetic screening, have vital clinical importance in guiding prognosis, targeted treatment, and family screening decisions for paediatric tumours.\n                  <\/jats:p>","DOI":"10.1038\/s41388-024-03137-7","type":"journal-article","created":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T03:02:46Z","timestamp":1726196566000},"page":"3268-3276","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Multifocal, multiphenotypic tumours arising from an MTOR mutation acquired in early embryogenesis"],"prefix":"10.1038","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4404-8183","authenticated-orcid":false,"given":"Clarissa N.","family":"Pacyna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhanagopal","family":"Anandapadamanaban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin W.","family":"Loudon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iain M.","family":"Hay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Perisic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5337-9729","authenticated-orcid":false,"given":"Ruoyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Allen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsty","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvette","family":"Hooks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1170-7867","authenticated-orcid":false,"given":"Anne Y.","family":"Warren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3188-9140","authenticated-orcid":false,"given":"Grant D.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Menna R.","family":"Clatworthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah A.","family":"Teichmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6600-7665","authenticated-orcid":false,"given":"Sam","family":"Behjati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3921-0510","authenticated-orcid":false,"given":"Peter J.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7754-4207","authenticated-orcid":false,"given":"Roger L.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0761-9503","authenticated-orcid":false,"given":"Thomas J.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,13]]},"reference":[{"key":"3137_CR1","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1158\/1078-0432.CCR-17-0702","volume":"23","author":"GM Brodeur","year":"2017","unstructured":"Brodeur GM, Nichols KE, Plon SE, Schiffman JD, Malkin D. Pediatric cancer predisposition and surveillance: an overview, and a tribute to Alfred G. Knudson Jr. Clin Cancer Res. 2017;23:e1\u20135.","journal-title":"Clin Cancer Res"},{"key":"3137_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41525-022-00291-3","volume":"7","author":"LE Oldfield","year":"2022","unstructured":"Oldfield LE, Grzybowski J, Grenier S, Chao E, Downs GS, Farncombe KM, et al. VHL mosaicism: the added value of multi-tissue analysis. NPJ Genom Med. 2022;7:1\u20135.","journal-title":"NPJ Genom Med"},{"key":"3137_CR3","doi-asserted-by":"publisher","first-page":"13950","DOI":"10.1073\/pnas.94.25.13950","volume":"94","author":"KB Gale","year":"1997","unstructured":"Gale KB, Ford AM, Repp R, Borkhardt A, Keller C, Eden OB, et al. Backtracking leukemia to birth: Identification of clonotypic gene fusion sequences in neonatal blood spots. Proc Natl Acad Sci USA. 1997;94:13950\u20134.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3137_CR4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41586-021-03548-6","volume":"595","author":"M Spencer Chapman","year":"2021","unstructured":"Spencer Chapman M, Ranzoni AM, Myers B, Williams N, Coorens THH, Mitchell E, et al. Lineage tracing of human development through somatic mutations. Nature. 2021;595:85\u201390.","journal-title":"Nature"},{"key":"3137_CR5","doi-asserted-by":"publisher","first-page":"104360","DOI":"10.1016\/j.ejmg.2021.104360","volume":"64","author":"V Steinke-Lange","year":"2021","unstructured":"Steinke-Lange V, de Putter R, Holinski-Feder E, Claes KB. Somatic mosaics in hereditary tumor predisposition syndromes. Eur J Med Genet. 2021;64:104360.","journal-title":"Eur J Med Genet"},{"key":"3137_CR6","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.3390\/ijms23052603","volume":"23","author":"F Trevisani","year":"2022","unstructured":"Trevisani F, Floris M, Minnei R, Cinque A. Renal oncocytoma: the diagnostic challenge to unmask the double of renal cancer. Int J Mol Sci. 2022;23:2603.","journal-title":"Int J Mol Sci"},{"key":"3137_CR7","first-page":"0","volume":"0","author":"X Wei","year":"2022","unstructured":"Wei X, Wang Y, Fang Y, Chen L. Renal oncocytoma in a 13-year-old girl: a case report and literature review. Indian J Pathol Microbiol. 2022;0:0.","journal-title":"Indian J Pathol Microbiol"},{"key":"3137_CR8","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1002\/cncr.31578","volume":"124","author":"MM Cajaiba","year":"2018","unstructured":"Cajaiba MM, Dyer LM, Geller JI, Jennings LJ, George D, Kirschmann D, et al. The classification of pediatric and young adult renal cell carcinomas registered on the children\u2019s oncology group (COG) protocol AREN03B2 after focused genetic testing. Cancer. 2018;124:3381\u20139.","journal-title":"Cancer"},{"key":"3137_CR9","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jpurol.2011.09.010","volume":"8","author":"J Wang","year":"2012","unstructured":"Wang J, Shehata BM, Langness SM, Davis GK, Cheng L, Osunkoya AO. Clear cell, papillary and chromophobe renal cell carcinoma in patients younger than 20 years old: A clinicopathologic study with follow-up. J Pediatr Urol. 2012;8:531\u20134.","journal-title":"J Pediatr Urol"},{"key":"3137_CR10","unstructured":"Moore KL, Persaud TVN, Torchia MG. The Developing Human: Clinically Oriented Embryology. 10th ed. Elsevier - Health Sciences Division, 2015."},{"key":"3137_CR11","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q","volume":"6","author":"DP Slaughter","year":"1953","unstructured":"Slaughter DP, Southwick HW, Smejkal W. \u201cField cancerization\u201d in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer. 1953;6:963\u20138.","journal-title":"Cancer"},{"key":"3137_CR12","doi-asserted-by":"publisher","first-page":"3263","DOI":"10.1158\/0008-5472.CAN-22-0121","volume":"82","author":"AA Bielska","year":"2022","unstructured":"Bielska AA, Harrigan CF, Kyung YJ, Morris Q, Palm W, Thompson CB. Activating mTOR mutations are detrimental in nutrient-poor conditions. Cancer Res. 2022;82:3263\u201374.","journal-title":"Cancer Res"},{"key":"3137_CR13","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1158\/2159-8290.CD-13-0929","volume":"4","author":"BC Grabiner","year":"2014","unstructured":"Grabiner BC, Nardi V, Birsoy K, Possemato R, Shen K, Sinha S, et al. A diverse array of cancer-associated MTOR mutations are hyperactivating and can predict rapamycin sensitivity. Cancer Discov. 2014;4:554\u201363.","journal-title":"Cancer Discov"},{"key":"3137_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41698-020-00139-y","volume":"5","author":"N Coleman","year":"2021","unstructured":"Coleman N, Subbiah V, Pant S, Patel K, Roy-Chowdhuri S, Yedururi S, et al. Emergence of mTOR mutation as an acquired resistance mechanism to AKT inhibition, and subsequent response to mTORC1\/2 inhibition. NPJ Precis Oncol. 2021;5:1\u20137.","journal-title":"NPJ Precis Oncol"},{"key":"3137_CR15","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/nature25023","volume":"552","author":"H Yang","year":"2017","unstructured":"Yang H, Jiang X, Li B, Yang HJ, Miller M, Yang A, et al. Mechanisms of mTORC1 activation by RHEB and inhibition by PRAS40. Nature. 2017;552:368\u201373.","journal-title":"Nature"},{"key":"3137_CR16","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.ccr.2014.07.014","volume":"26","author":"CF Davis","year":"2014","unstructured":"Davis CF, Ricketts CJ, Wang M, Yang L, Cherniack AD, Shen H, et al. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell. 2014;26:319\u201330.","journal-title":"Cancer Cell"},{"key":"3137_CR17","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/j.celrep.2015.10.059","volume":"13","author":"S Joshi","year":"2015","unstructured":"Joshi S, Tolkunov D, Aviv H, Hakimi AA, Yao M, Hsieh JJ, et al. The genomic landscape of renal oncocytoma identifies a metabolic barrier to tumorigenesis. Cell Rep. 2015;13:1895\u2013908.","journal-title":"Cell Rep"},{"key":"3137_CR18","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.gene.2017.09.044","volume":"640","author":"LS Schmidt","year":"2018","unstructured":"Schmidt LS, Linehan WM. FLCN: the causative gene for Birt-Hogg-Dub\u00e9 syndrome. Gene. 2018;640:28\u201342.","journal-title":"Gene"},{"key":"3137_CR19","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1038\/s41379-021-00779-w","volume":"34","author":"K Trpkov","year":"2021","unstructured":"Trpkov K, Hes O, Williamson SR, Adeniran AJ, Agaimy A, Alaghehbandan R, et al. New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia. Mod Pathol. 2021;34:1392\u2013424.","journal-title":"Mod Pathol"},{"key":"3137_CR20","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1097\/PAS.0000000000001422","volume":"44","author":"RB Shah","year":"2020","unstructured":"Shah RB, Stohr BA, Tu ZJ, Gao Y, Przybycin CG, Nguyen J, et al. \u201cRenal cell carcinoma with leiomyomatous stroma\u201d characterization of 18 sporadic tumors supports a distinct entity. Am J Surg Pathol. 2020;44:571\u201381.","journal-title":"Am J Surg Pathol"},{"key":"3137_CR21","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/S0140-6736(08)61039-9","volume":"372","author":"RJ Motzer","year":"2008","unstructured":"Motzer RJ, Escudier B, Oudard S, Hutson TE, Porta C, Bracarda S, et al. Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial. Lancet. 2008;372:449\u201356.","journal-title":"Lancet"},{"key":"3137_CR22","doi-asserted-by":"publisher","first-page":"3526","DOI":"10.1172\/JCI86120","volume":"126","author":"J Xu","year":"2016","unstructured":"Xu J, Pham CG, Albanese SK, Dong Y, Oyama T, Lee C, et al. Mechanistically distinct cancer-associated mTOR activation clusters predict sensitivity to rapamycin. J Clin Invest. 2016;126:3526\u201340.","journal-title":"J Clin Invest"},{"key":"3137_CR23","doi-asserted-by":"publisher","first-page":"17895","DOI":"10.18632\/oncotarget.4963","volume":"6","author":"AP Ghosh","year":"2015","unstructured":"Ghosh AP, Marshall CB, Coric T, Shim E-H, Kirkman R, Ballestas ME, et al. Point mutations of the mTOR-RHEB pathway in renal cell carcinoma. Oncotarget. 2015;6:17895\u2013910.","journal-title":"Oncotarget"},{"key":"3137_CR24","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41586-021-04312-6","volume":"602","author":"N Williams","year":"2022","unstructured":"Williams N, Lee J, Mitchell E, Moore L, Baxter EJ, Hewinson J, et al. Life histories of myeloproliferative neoplasms inferred from phylogenies. Nature. 2022;602:162\u20138.","journal-title":"Nature"},{"key":"3137_CR25","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/s41591-022-01720-7","volume":"28","author":"E Khabirova","year":"2022","unstructured":"Khabirova E, Jardine L, Coorens THH, Webb S, Treger TD, Engelbert J, et al. Single-cell transcriptomics reveals a distinct developmental state of KMT2A-rearranged infant B-cell acute lymphoblastic leukemia. Nat Med. 2022;28:743\u201351.","journal-title":"Nat Med"},{"key":"3137_CR26","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1126\/science.aax1323","volume":"366","author":"THH Coorens","year":"2019","unstructured":"Coorens THH, Treger TD, Al-Saadi R, Moore L, Tran MGB, Mitchell TJ, et al. Embryonal precursors of Wilms tumor. Science. 2019;366:1247\u201351.","journal-title":"Science"},{"key":"3137_CR27","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1016\/j.ccell.2022.11.001","volume":"40","author":"R Li","year":"2022","unstructured":"Li R, Ferdinand JR, Loudon KW, Campbell PJ, Teichmann SA, Mitchell TJ, et al. Mapping single-cell transcriptomes in the intra- tumoral and associated territories of kidney cancer ll Mapping single-cell transcriptomes in the intra-tumoral and associated territories of kidney cancer. Cancer Cell. 2022;40:1583\u201399.","journal-title":"Cancer Cell"},{"key":"3137_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23949-5","volume":"12","author":"MD Young","year":"2021","unstructured":"Young MD, Mitchell TJ, Custers L, Margaritis T, Morales-rodriguez F, Kwakwa K, et al. Single cell derived mRNA signals across human kidney tumors. Nat Commun. 2021;12:3896.","journal-title":"Nat Commun"},{"key":"3137_CR29","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1126\/science.aat1699","volume":"361","author":"MD Young","year":"2018","unstructured":"Young MD, Mitchell TJ, Vieira Braga FA, B Tran MG, Stewart BJ, Ferdinand JR, et al. Single-cell transcriptomes from human kidneys reveal the cellular identity of renal tumors. Science. 2018;361:594\u20139.","journal-title":"Science"},{"key":"3137_CR30","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1126\/science.aax3939","volume":"366","author":"M Anandapadamanaban","year":"2019","unstructured":"Anandapadamanaban M, Masson GR, Perisic O, Berndt A, Kaufman J, Johnson CM, et al. Architecture of human Rag GTPase heterodimers and their complex with mTORC1. Science. 2019;366:203\u201310.","journal-title":"Science"},{"key":"3137_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/eLife.68799","volume":"10","author":"M Heimhalt","year":"2021","unstructured":"Heimhalt M, Berndt A, Wagstaff J, Anandapadamanaban M, Perisic O, Maslen S, et al. Bipartite binding and partial inhibition links DEPTOR and mTOR in a mutually antagonistic embrace. Elife. 2021;10:1\u201338.","journal-title":"Elife"},{"key":"3137_CR32","doi-asserted-by":"publisher","first-page":"17833","DOI":"10.1073\/pnas.1419425111","volume":"111","author":"A Jain","year":"2014","unstructured":"Jain A, Arauz E, Aggarwal V, Ikon N, Chen J, Ha T. Stoichiometry and assembly of mTOR complexes revealed by single-molecule pulldown. Proc Natl Acad Sci. 2014;111:17833\u20138.","journal-title":"Proc Natl Acad Sci"},{"key":"3137_CR33","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.molcel.2016.12.028","volume":"65","author":"M Ebner","year":"2017","unstructured":"Ebner M, Lu\u010di\u0107 I, Leonard TA, Yudushkin I. PI(3,4,5)P3 engagement restricts akt activity to cellular membranes. Mol Cell. 2017;65:416\u2013.e6.","journal-title":"Mol Cell"},{"key":"3137_CR34","doi-asserted-by":"publisher","unstructured":"Zivanov J, Nakane T, Forsberg BO, Kimanius D, Hagen WJ, Lindahl E et al. New tools for automated high-resolution cryo-EM structure determination in RELION-3. Elife 2018; 7. https:\/\/doi.org\/10.7554\/eLife.42166.","DOI":"10.7554\/eLife.42166"},{"key":"3137_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsb.2015.11.003","volume":"193","author":"K Zhang","year":"2016","unstructured":"Zhang K. Gctf: Real-time CTF determination and correction. J Struct Biol. 2016;193:1\u201312.","journal-title":"J Struct Biol"},{"key":"3137_CR36","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nmeth.4193","volume":"14","author":"SQ Zheng","year":"2017","unstructured":"Zheng SQ, Palovcak E, Armache J-P, Verba KA, Cheng Y, Agard DA. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat Methods. 2017;14:331\u20132.","journal-title":"Nat Methods"},{"key":"3137_CR37","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/nmeth.2727","volume":"11","author":"A Kucukelbir","year":"2014","unstructured":"Kucukelbir A, Sigworth FJ, Tagare HD. Quantifying the local resolution of cryo-EM density maps. Nat Methods. 2014;11:63\u20135.","journal-title":"Nat Methods"},{"key":"3137_CR38","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.jmb.2003.07.013","volume":"333","author":"PB Rosenthal","year":"2003","unstructured":"Rosenthal PB, Henderson R. Optimal determination of particle orientation, absolute hand, and contrast loss in single-particle electron cryomicroscopy. J Mol Biol. 2003;333:721\u201345.","journal-title":"J Mol Biol"},{"key":"3137_CR39","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.jsb.2012.09.006","volume":"180","author":"SHW Scheres","year":"2012","unstructured":"Scheres SHW. RELION: implementation of a Bayesian approach to cryo-EM structure determination. J Struct Biol. 2012;180:519\u201330.","journal-title":"J Struct Biol"},{"key":"3137_CR40","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, et al. UCSF Chimera\u2013a visualization system for exploratory research and analysis. J Comput Chem. 2004;25:1605\u201312.","journal-title":"J Comput Chem"},{"key":"3137_CR41","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr Sect D. 2004;60:2126\u201332.","journal-title":"Acta Crystallogr Sect D"},{"key":"3137_CR42","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/nmeth.4347","volume":"14","author":"YZ Tan","year":"2017","unstructured":"Tan YZ, Baldwin PR, Davis JH, Williamson JR, Potter CS, Carragher B, et al. Addressing preferred specimen orientation in single-particle cryo-EM through tilting. Nat Methods. 2017;14:793\u20136.","journal-title":"Nat Methods"},{"key":"3137_CR43","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41596-022-00757-9","volume":"18","author":"W Lugmayr","year":"2023","unstructured":"Lugmayr W, Kotov V, Goessweiner-Mohr N, Wald J, DiMaio F, Marlovits TC. StarMap: a user-friendly workflow for Rosetta-driven molecular structure refinement. Nat Protoc. 2023;18:239\u201364.","journal-title":"Nat Protoc"},{"key":"3137_CR44","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nmeth.3286","volume":"12","author":"F DiMaio","year":"2015","unstructured":"DiMaio F, Song Y, Li X, Brunner MJ, Xu C, Conticello V, et al. Atomic-accuracy models from 4.5-\u00c5 cryo-electron microscopy data with density-guided iterative local refinement. Nat Methods. 2015;12:361\u20135.","journal-title":"Nat Methods"},{"key":"3137_CR45","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams PD, Afonine PV, Bunk\u00f3czi G, Chen VB, Davis IW, Echols N, et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr Sect D. 2010;66:213\u201321.","journal-title":"Acta Crystallogr Sect D"},{"key":"3137_CR46","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/pro.3330","volume":"7","author":"CJ Williams","year":"2018","unstructured":"Williams CJ, Headd JJ, Moriarty NW, Prisant MG, Videau LL, Deis LN, et al. MolProbity: more and better reference data for improved all-atom structure validation. Protein Sci. 2018;7:293\u2013315.","journal-title":"Protein Sci"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-024-03137-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-024-03137-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-024-03137-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T13:03:53Z","timestamp":1730120633000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-024-03137-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,13]]},"references-count":46,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2024,10,28]]}},"alternative-id":["3137"],"URL":"https:\/\/doi.org\/10.1038\/s41388-024-03137-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.12.12.570785","asserted-by":"object"}]},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,13]]},"assertion":[{"value":"21 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.A.T. is a scientific advisory board member of ForeSite Labs, Qiagen and Element Biosciences, and a co-founder and equity holder of TransitionBio and EnsoCell Therapeutics, and a part-time employee of GlaxoSmithKline. P.J.C. is an academic co-founder for Quotient Therapeutics.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All research in this study involving human subjects, human material, or human data is in accordance with the Declaration of Helsinki. Human material was obtained from patients enroled in an UK NHS REC approved study (reference 16\/EE\/0394). In accordance with the REC requirements, consent was obtained from all subjects. As no patient photographs were used, consent to publish images was not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}